Dec 1, 2023, 14:18 by Molly McGrath

ASAM supported removing barriers to smoking cessation products to provide more people better access to these tools.

Nov 30, 2023, 15:48 by Molly McGrath

Nov 29, 2023, 08:44 by Molly McGrath

MDDCSAM and ASAM expressed their shared concern regarding rising opioid-related overdose deaths in Washington, DC, attributed primarily to high-potency synthetic opioids (HPSOs), including fentanyl and its analogs.

Nov 28, 2023, 13:12 by Bob Davis

SAMHSA recently released results from the 2022 National Survey on Drug Use and Health (NSDUH). While further analysis of the data is expected to follow, many of our featured publications this week provide important context for the numbers.

Nov 27, 2023, 18:52 by Molly McGrath

On November 21, ASAM sent a letter to the leadership of the Senate Committee on Health, Education, Labor and Pensions (HELP), urging strong policymaking to tackle America's substance use challenges. Outlining five policy solutions that interlock for an exponentially stronger approach to the U.S.'s addiction and overdose crisis, ASAM urged the Committee's leadership...

Nov 22, 2023, 12:09 by Bob Davis

If you're a little apprehensive this year about having awkward or even anxiety-provoking Thanksgiving conversations, then we’ve got you covered.

Nov 17, 2023, 18:49 by Molly McGrath

ASAM joined the American Medical Association, many state medical associations and other national medical specialty societies in urging Congress to quickly pass legislation to stop another impending round of Medicare payment cuts.

Nov 14, 2023, 12:00 by ASAM Weekly Editors

How we frame the problem significantly impacts individuals with addiction. A global review of legislative approaches toward gambling demonstrates how some countries are still warming to a systemic, public health approach while many are mostly focused on vulnerable individuals and promoting responsible gambling (Lancet Public Health).

Nov 7, 2023, 12:00 by Weekly Editors

As we presented last week, ASAM provides expert guidance for the field of addiction medicine. Today, the American Society of Addiction Medicine (ASAM) and the American Academy of Addiction Psychiatry (AAAP) published the Clinical Practice Guideline on the Management of Stimulant Use Disorder.

Nov 7, 2023, 08:31 by Bob Davis

The American Society of Addiction Medicine (ASAM) and the American Academy of Addiction Psychiatry (AAAP) have jointly developed a crucial Clinical Practice Guideline on the Management of Stimulant Use Disorder (StUD). This groundbreaking guideline is designed to provide evidence-based strategies and clinically informed standards of care for the prevention and treatment of StUD, stimulant intoxication, and stimulant withdrawal.

Nov 3, 2023, 15:32 by Molly McGrath

ASAM recently joined several organizations in a sign-on letter applauding the Substance Abuse and Mental Health Services Administration’s (SAMHSA) proposed harm reduction framework designed to better integrate such strategies throughout the agency's policies and programming.

Nov 3, 2023, 15:24 by Molly McGrath

ASAM joined several national medical specialty societies and other advocates to raise concerns about the health insurer, Aetna’s recent decision to terminate several services for the treatment of mental health (MH) disorders and substance use disorder (SUD) via telehealth, effective December 1, 2023.

Nov 2, 2023, 12:09 by Molly McGrath

ASAM joined other stakeholders in a letter to the leadership of the U.S. House Committee on Agriculture and the U.S. Senate Committee on Agriculture, Nutrition, and Forestry, supporting the inclusion of the Re-Entry Support Through Opportunities for Resources and Essentials (RESTORE) Act of 2023 (H.R. 3479/S.1753) in the 2023 Farm Bill.

Nov 2, 2023, 11:44 by Molly McGrath

On October 31st, the Pennsylvania Society of Addiction Medicine (PSAM) sent a letter to state Senator Dan Laughlin expressing concern with his recently introduced legislation, SB 962. This legislation would expand Pennsylvania’s statutes to establish an involuntary commitment process for individuals administered opioid antagonists in response to a drug overdose.

Nov 1, 2023, 22:03 by Molly McGrath

Nov 1, 2023, 18:44 by Molly McGrath

Oct 31, 2023, 12:00 by ASAM Weekly Editors

If you haven’t recently explored the ASAM website, this week’s publications may be a good motivation to do so.

Oct 27, 2023, 15:31 by Molly McGrath

Oct 24, 2023, 12:00 by ASAM Weekly Editors

Stuff happens as we move substance use along the spectrum between criminalization and commercialization.

Oct 17, 2023, 22:59 by Molly McGrath